Structures by: Bruni B.
Total: 24
2,3-bis(4-benzyloxy-3-methoxy-benzilidene)-succinic acid methanol solvate
C34H30O8.C1H4O1
New Journal of Chemistry (2006) 30, 4 647
a=10.6859(4)Å b=10.7325(4)Å c=14.5858(5)Å
α=73.297(3)° β=74.559(3)° γ=77.321(3)°
2,3-bis(4-benzyloxy-3-methoxy-benzilidene)-succinic acid buthanol solvate
C34H30O8.C4H10O1
New Journal of Chemistry (2006) 30, 4 647
a=10.929(1)Å b=11.708(1)Å c=15.385(2)Å
α=101.68(1)° β=106.69(1)° γ=96.91(1)°
C7H11N2O
C7H11N2O
CrystEngComm (2008)
a=7.143(2)Å b=6.409(1)Å c=15.748(3)Å
α=90.00° β=90.14(3)° γ=90.00°
Propafenone hydrochloride
C21H28NO3,Cl
Acta Crystallographica Section E (2006) 62, 5 o1694-o1695
a=7.7090(10)Å b=15.959(2)Å c=16.007(2)Å
α=90.00° β=90.490(10)° γ=90.00°
Gemfibrozil
C15H22O3
Acta Crystallographica Section E (2005) 61, 7 o1989-o1991
a=14.8610(10)Å b=7.3640(10)Å c=27.948(2)Å
α=90.00° β=93.420(10)° γ=90.00°
(S)-(+)-2-(2-biphenyl-2-yl-1-methylethyl)-4,5-dihydro-1H-imidazolium hydrogen oxalate
C18H21N2,C2HO4
Acta Crystallographica Section E (2005) 61, 8 o2376-o2378
a=9.4761(6)Å b=10.0886(6)Å c=10.5018(6)Å
α=90.00° β=111.697(6)° γ=90.00°
Mepivacaine hydrochloride
C15H23N2O,Cl
Acta Crystallographica Section E (2005) 61, 3 o585-o586
a=9.7378(10)Å b=10.5790(9)Å c=15.2761(15)Å
α=90.00° β=90.00° γ=90.00°
C6H7AuCl3NO
C6H7AuCl3NO
Acta Crystallographica Section C (1996) 52, 6 1423-1424
a=7.826(2)Å b=14.606(4)Å c=8.830(3)Å
α=90° β=96.58(2)° γ=90°
Dimesna
2Na,C4H8O6S42,3H2O
Acta Crystallographica Section E (2007) 63, 7 m1948-m1948
a=5.7328(2)Å b=10.9152(4)Å c=11.2665(4)Å
α=90.00° β=97.106(4)° γ=90.00°
3-Methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl 4-aminobenzoate
C18H13NO4
Acta Crystallographica Section E (2008) 64, 4 o718
a=7.6217(6)Å b=9.6142(7)Å c=10.6456(7)Å
α=101.618(6)° β=110.770(7)° γ=89.019(6)°
Mesna
Na,C2H5O3S2
Acta Crystallographica Section E (2007) 63, 7 o1796-o1796
a=6.1458(3)Å b=8.2749(4)Å c=24.2995(11)Å
α=90.00° β=90.00° γ=90.00°
Lidocaine
C14H22N2O
Acta Crystallographica Section E (2007) 63, 2 o768-o770
a=12.9590(3)Å b=13.8003(3)Å c=18.8288(5)Å
α=90.00° β=122.340(3)° γ=90.00°
Diisopropyl{2-[2-(2-oxopyrrolidin-1-yl)acetamido]ethyl}ammonium hydrogen sulfate
C14H28N3O2,HO4S
Acta Crystallographica Section E (2008) 64, 6 o1160
a=6.7834(3)Å b=11.1755(4)Å c=12.9012(6)Å
α=72.165(4)° β=89.394(4)° γ=89.509(3)°
2,4-Dichlorobenzyl alcohol
C7H6Cl2O
Acta Crystallographica Section E (2007) 63, 1 o275-o276
a=4.7361(4)Å b=12.8179(13)Å c=24.853(2)Å
α=90.00° β=96.852(8)° γ=90.00°
Irbesartan chloride 1.69-hydrate
C25H29N6O,Cl,1.69(H2O)
Acta Crystallographica Section E (2007) 63, 4 o1529-o1531
a=8.5557(3)Å b=25.0130(8)Å c=12.2675(4)Å
α=90.00° β=104.415(3)° γ=90.00°
2-(1,2,3,4-Tetrahydro-1-naphthyl)imidazolium chloride monohydrate
C13H15N2,Cl,H2O
Acta Crystallographica Section E (2010) 66, 9 o2321
a=9.82990(10)Å b=12.6671(2)Å c=10.5375(2)Å
α=90.00° β=92.6660(10)° γ=90.00°
4-Amino-<i>N</i>-(3-methoxypyrazin-2-yl)benzenesulfonamide
C11H12N4O3S
Acta Crystallographica Section E (2010) 66, 10 o2663
a=10.7589(2)Å b=9.5652(2)Å c=24.5586(4)Å
α=90.00° β=90.00° γ=90.00°
Torasemide methanol 0.25-solvate 0.25-hydrate
C16H20N4O3S1,0.25(CH4O),0.25(H2O)
Acta Crystallographica Section E (2009) 65, 5 o970-o971
a=16.8477(2)Å b=11.59510(10)Å c=20.3256(2)Å
α=90.00° β=108.6460(10)° γ=90.00°
Metoprolol succinate
C15H26N1O3,0.5(C4H4O42)
Acta Crystallographica Section E (2009) 65, 6 o1364-o1365
a=26.2630(4)Å b=7.9396(2)Å c=17.4629(4)Å
α=90.00° β=107.348(2)° γ=90.00°
[(C9H4CLINO1)2,(Zn2),(H2O)]2,(C4H8O),(H2O)
[(C9H4CLINO1)2,(Zn2),(H2O)]2,(C4H8O),(H2O)
Inorganic Chemistry (2004) 43, 3795-3797
a=10.265(5)Å b=11.432(5)Å c=20.320(5)Å
α=99.610(5)° β=95.560(5)° γ=92.510(5)°
C18H8Cl2CuI2N2O2
C18H8Cl2CuI2N2O2
Inorganic Chemistry (2004) 43, 3795-3797
a=4.880(4)Å b=10.827(5)Å c=18.012(7)Å
α=90.00° β=91.13(7)° γ=90.00°
C4H12Cd2O14
C4H12Cd2O14
Inorganic Chemistry (2002) 41, 4312-4314
a=6.0100(10)Å b=6.6680(10)Å c=8.4980(10)Å
α=74.640(10)° β=74.250(10)° γ=80.910(10)°
Terbium(III) quinizarine-2-sulphonate hexahydrate
C28H27O21S2Tb
Inorganic Chemistry (2003) 42, 3157-3159
a=8.6580(10)Å b=10.5270(10)Å c=17.7630(10)Å
α=97.470(10)° β=90.640(10)° γ=94.650(10)°
Torasemide
C16H20N4O3S
Acta Crystallographica Section E (2009) 65, 5 o972-o973
a=11.33780(10)Å b=18.90550(10)Å c=16.49580(10)Å
α=90.00° β=94.2730(10)° γ=90.00°